Exercise-Induced Oxygen Desaturation as a Predictive Factor for Longitudinal Decline in 6-Minute Walk Distance in Subjects With COPD

References

1. 1.↵
   1. Nici L,
   2. Donner C,
   3. Wouters E,
   4. Zuwallack R,
   5. Ambrosino N,
   6. Bourbeau J,
   7. et al

   . American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390–1413.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Celli BR,
   2. Cote CG,
   3. Marin JM,
   4. Casanova C,
   5. Montes de Oca M,
   6. Mendez RA,
   7. et al

   . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005–1012.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Spruit MA,
   2. Polkey MI,
   3. Celli B,
   4. Edwards LD,
   5. Watkins ML,
   6. Pinto-Plata V,
   7. et al

   . Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012;13(3):291–297.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Pinto-Plata VM,
   2. Cote C,
   3. Cabral H,
   4. Taylor J,
   5. Celli BR

   . The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23(1):28–33.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Casanova C,
   2. Cote CG,
   3. Marin JM,
   4. de Torres JP,
   5. Aguirre-Jaime A,
   6. Mendez R,
   7. et al

   . The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007;29(3):535–540.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Frisk B,
   2. Espehaug B,
   3. Hardie JA,
   4. Strand LI,
   5. Moe-Nilssen R,
   6. Eagan TM,
   7. et al

   . Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir Med 2014;108(1):86–94.

   OpenUrl
7. 7.↵
   1. Cortopassi F,
   2. Celli B,
   3. Divo M,
   4. Pinto-Plata V

   . Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group. Chest 2015;148(4):986–994.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Diaz AA,
   2. Pinto-Plata V,
   3. Hernandez C,
   4. Pena J,
   5. Ramos C,
   6. Diaz JC,
   7. et al

   . Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. Respir Med 2015;109(7):882–889.

   OpenUrlPubMed
9. 9.↵
   1. Ramon MA,
   2. Gimeno-Santos E,
   3. Ferrer J,
   4. Balcells E,
   5. Rodriguez E,
   6. de Batlle J,
   7. et al

   . Hospital admissions and exercise capacity decline in patients with COPD. Eur Respir J 2014;43(4):1018–1027.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Stolz D,
    2. Boersma W,
    3. Blasi F,
    4. Louis R,
    5. Milenkovic B,
    6. Kostikas K,
    7. et al

    . Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 2014;146(2):328–338.

    OpenUrl
11. 11.↵
    1. van Gestel AJ,
    2. Clarenbach CF,
    3. Stowhas AC,
    4. Teschler S,
    5. Russi EW,
    6. Teschler H,
    7. et al

    . Prevalence and prediction of exercise-induced oxygen desaturation in patients with chronic obstructive pulmonary disease. Respiration 2012;84(5):353–359.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Kim C,
    2. Seo JB,
    3. Lee SM,
    4. Lee JS,
    5. Huh JW,
    6. Lee JH,
    7. et al

    . Exertional desaturation as a predictor of rapid lung function decline in COPD. Respiration 2013;86(2):109–116.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Casanova C,
    2. Cote C,
    3. Marin JM,
    4. Pinto-Plata V,
    5. de Torres JP,
    6. Aguirre-Jaime A,
    7. et al

    . Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134(4):746–752.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Takigawa N,
    2. Tada A,
    3. Soda R,
    4. Date H,
    5. Yamashita M,
    6. Endo S,
    7. et al

    . Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007;101(3):561–567.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Waatevik M,
    2. Johannessen A,
    3. Gomez Real F,
    4. Aanerud M,
    5. Hardie JA,
    6. Bakke PS,
    7. et al

    . Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD. Eur Respir J 2016;48(1):82–91.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Andrianopoulos V,
    2. Franssen FM,
    3. Peeters JP,
    4. Ubachs TJ,
    5. Bukari H,
    6. Groenen M,
    7. et al

    . Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol 2014;190:40–46.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Oki Y,
    2. Kaneko M,
    3. Fujimoto Y,
    4. Sakai H,
    5. Misu S,
    6. Mitani Y,
    7. et al

    . Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2869–2875.

    OpenUrl
18. 18.↵
    1. Golpe R,
    2. Perez-de-Llano LA,
    3. Mendez-Marote L,
    4. Veres-Racamonde A

    . Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Respir Care 2013;58(8):1329–1334.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Andrianopoulos V,
    2. Wouters EF,
    3. Pinto-Plata VM,
    4. Vanfleteren LE,
    5. Bakke PS,
    6. Franssen FM,
    7. et al

    . Prognostic value of variables derived from the six-minute walk test in patients with COPD: results from the ECLIPSE study. Respir Med 2015;109(9):1138–1146.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Kent BD,
    2. Mitchell PD,
    3. McNicholas WT

    . Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199–208.

    OpenUrlPubMed
21. 21.↵
    1. Regan EA,
    2. Lynch DA,
    3. Curran-Everett D,
    4. Curtis JL,
    5. Austin JH,
    6. Grenier PA,
    7. et al

    . Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 2015;175(9):1539–1549.

    OpenUrl
22. 22.
    1. Harvey BG,
    2. Strulovici-Barel Y,
    3. Kaner RJ,
    4. Sanders A,
    5. Vincent TL,
    6. Mezey JG,
    7. et al

    . Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity. Eur Respir J 2015;46(6):1589–1597.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Lutchmedial SM,
    2. Creed WG,
    3. Moore AJ,
    4. Walsh RR,
    5. Gentchos GE,
    6. Kaminsky DA

    . How common is airflow limitation in patients with emphysema on CT scan of the chest? Chest 2015;148(1):176–184.

    OpenUrlCrossRefPubMed
24. 24.↵
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Puhan MA,
    2. Chandra D,
    3. Mosenifar Z,
    4. Ries A,
    5. Make B,
    6. Hansel NN,
    7. et al

    . The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011;37(4):784–790.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Holland AE,
    2. Hill CJ,
    3. Rasekaba T,
    4. Lee A,
    5. Naughton MT,
    6. McDonald CF

    . Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010;91(2):221–225.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Polkey MI,
    2. Spruit MA,
    3. Edwards LD,
    4. Watkins ML,
    5. Pinto-Plata V,
    6. Vestbo J,
    7. et al

    . Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187(4):382–386.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Casaburi R,
    2. Cooper JA Jr.,
    3. Criner GJ,
    4. et al

    1. Albert RK,
    2. Au DH

    , Blackford air-flow limitation, Casaburi R, Cooper JA Jr., Criner GJ, et al. A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med 2016;375(17):1617–1627.

    OpenUrlPubMed
29. 29.↵
    1. Parshall MB,
    2. Schwartzstein RM,
    3. Adams L,
    4. Banzett RB,
    5. Manning HL,
    6. Bourbeau J,
    7. et al

    . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185(4):435–452.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Garcia-Talavera I,
    2. Garcia CH,
    3. Macario CC,
    4. de Torres JP,
    5. Celli BR,
    6. Aguirre-Jaime A

    . Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg. Respir Med 2008;102(7):1026–1032.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Scott AS,
    2. Baltzman MA,
    3. Chan R,
    4. Wolkove N

    . Oxygen desaturation during a 6-min walk test is a sign of nocturnal hypoxemia. Can Respir J 2011;18(6):333–337.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Panos RJ,
    2. Eschenbacher W

    . Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD 2009;6(6):478–487.

    OpenUrl
33. 33.↵
    1. Zafar MA,
    2. Tsuang W,
    3. Lach L,
    4. Eschenbacher W,
    5. Panos RJ

    . Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung 2013;191(2):177–182.

    OpenUrlPubMed
34. 34.↵
    1. Hernandes NA,
    2. Wouters EF,
    3. Meijer K,
    4. Annegarn J,
    5. Pitta F,
    6. Spruit MA

    . Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011;38(2):261–267.

    OpenUrlAbstract/FREE Full Text